Light therapy added to brain cancer surgery in experimental treatment
NCT ID NCT04391062
Summary
This study tested whether increasing the light dose during a special light-activated therapy could help control glioblastoma, an aggressive brain cancer. The treatment was given during surgery to remove the tumor, then patients received standard radiation and chemotherapy. Researchers measured how much light could be safely used and whether it helped delay cancer regrowth or improved survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hopital Roger Salengro, CHU Lille
Lille, 59037, France
-
Hôpital Erasme, Clinique Universitaire de Bruxelles
Brussels, Belgium
Conditions
Explore the condition pages connected to this study.